chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: F
Vaccine: FLUX
Symptoms: Medication error
Clinical narrative: A report received from a health professional on 30Oct02, concerning approx 10 vaccinees who inadvertently received last year's formulation of Fluvirin. From 28Oct02 to 30Oct02, 20-30 staff members were vaccinated with Fluvirin. After finishing the vaccination, a staff member noticed that one of the used vials was last years vaccine (2001-2002). The vial was discarded, thus the batch number is not available. There was insufficient information to determine the reporters causality assessment. Update 1 27Jan03: A report was received from a health care professional concerning a 64 year old female vaccinee who received expired influenza vaccine (brand unspecified) on an unspecified date. The vaccinee was subsequently revaccinated with this years influenza vaccination and experienced no adverse reaction. See ref: PJP200200635, PJP200300049, PJP200300050, PJP200300051, PJP200300053, PJP200300054.
Age: 56.0
Sex: F
Vaccine: FLUX
Symptoms: Medication error
Clinical narrative: A report received from a health professional on 30Oct02, concerning approx 10 vaccinees who inadvertently received last year's formulation of Fluvirin. From 28Oct02 to 30Oct02, 20-30 staff members were vaccinated with Fluvirin. After finishing the vaccination, a staff member noticed that one of the used vials was last years vaccine (2001-2002). The vial was discarded, thus the batch number is not available. There was insufficient information to determine the reporters causality assessment. Update 1 27Jan03: A report was received from a health care professional concerning a 55 year old female vaccinee who received expired influenza vaccine (brand unspecified) on an unspecified date. The vaccinee was subsequently revaccinated with this years influenza vaccination and experienced no adverse reaction. See ref: PJP200200635, PJP200300049, PJP200300050, PJP200300051, PJP200300052, PJP200300054.
Age: 50.0
Sex: F
Vaccine: FLUX
Symptoms: Medication error
Clinical narrative: A report received from a health professional on 30Oct02, concerning approx 10 vaccinees who inadvertently received last years formulation of Fluvirin. From 28Oct02 to 30Oct02, 20-30 staff members were vaccinated with Fluvirin. After finishing the vaccination, a staff member noticed that one of the used vials was last years vaccine (2001-2002). The vial was discarded, thus the batch number is not available. There was insufficient information to determine the reporters causality assessment. Update 1 27Jan03: A report was received from a health care professional concerning a 50 year old female vaccinee who received expired influenza vaccine (brand unspecified) on an unspecified date. The vaccinee was subsequently revaccinated with this years influenza vaccination and experienced no adverse reaction. See ref: PJP200200635, PJP200300049, PJP200300050, PJP200300051, PJP200200052, PJP200300053.
Sex: M
Vaccine: FLU3
Symptoms: Influenza, Laboratory test abnormal, Myalgia, Pain, Pyrexia
Clinical narrative: A report received from a health professional on 06Feb03, concerning an adolescent male of an unspecified age who developed flu with fever, body aches and pain and unspecified length of time after receiving Fluvirin on an unspecified date between Nov and Dec 2002. On an unspecified date the vaccinee developed the flu with fever, body aches and pain. A nasal swab on an unspecified date in Feb03 was positive for Type A and Type B antigens. There was insufficient information to determine the reporters causality assessment.  Cross ref with: PJP200300060; PJP200300061, PJP200300062.
Sex: F
Vaccine: FLU3
Symptoms: Influenza, Myalgia, Pain, Pyrexia
Clinical narrative: A report received from a health professional on 06Feb03, concerning a sexagenarian female vaccinee who developed  flu with fever, body aches and pains an unspecified length of time after receiving Fluvirin on an unspecified date between Nov and Dec 2002. On an unspecified date the vaccinee developed the flu with fever, body aches and pain. A nasal swab on an unspecified date in Feb03 was positive for Type A and Type B antigens. There was insufficient information to determine the reporters causality assessment. Cross ref with: PJP200300059; PJP200300061, PJP200300062.
Age: 40.0
Sex: F
Vaccine: FLU3
Symptoms: Influenza, Myalgia, Pain, Pyrexia
Clinical narrative: A report received from a health professional on 06Feb03, concerning a 40 year old female vaccinee who developed flu with fever, body aches and pains an unspecified length of time after receiving Fluvirin on an unspecified date between Nov and Dec 2002. On an unspecified date the vaccinee developed the flu with fever, body aches and pain. A nasal swab on an unspecified date in Feb03 was positive for Type A and Type B antigens. There was insufficient information to determine the reporters causality assessment. Cross ref with: PJP200300059; PJP200300060, PJP200300062.
Sex: F
Vaccine: FLU3
Symptoms: Influenza, Laboratory test abnormal, Myalgia, Pain, Pyrexia
Clinical narrative: A report was received from a health care professional on 6Feb03 concerning a female vaccinee between the ages of 30 and 40 years who developed the flu with fever, body aches and pain an unspecified length of time after receiving Fluvirin on an unspecified date between Nov and Dec 2002. On an unspecified date the vaccinee developed the flu with fever, body aches and pain. A nasal swab on an unspecified date in Feb03 was positive for Type A and Type B antigens. The vaccinees condition had improved at the time of the report. There was insufficient information to determine the reporters causality assessment. Cross ref with: PJP200300059, PJP200300060, PJP200300061.
Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Feeling hot, Injection site pain, Sleep disorder
Clinical narrative: A report was received from a health care professional on 24Feb03 concerning a 54 year old female vaccinee who experienced throbbing and warmth at the injection site an unspecified length of time after receiving Fluvirin on an unk date in Oct02. On an unk date in Oct02 the vaccinee experienced throbbing and warmth in her left deltoid shortly after receiving Fluvirin. The area was warm but not red or swollen and the vaccinee had no fever. The vaccinee had a history of fibromyalgia which was under control at the time of vaccination. The vaccinee received the flu vaccination in the past and experienced no adverse event. The throbbing and warmth had not resolved at the time of the report. The reporter has assessed the relationship of the vaccine to the event as unk. Update 1 25Mar03: A follow up report was received from a health care professional which stated that the vaccinee experienced throbbing in the left upper arm the day after she received Fluvirin on 18Oct02. There was no pain at the time of the injection or on the day of the injection. The arm was warm to touch, not swollen or erthemic. It was so painful at night that she needed to wrap arm in an ice wrap and take unspecified pain medication. The reporter diagnosed trigger point pain exacerbation of fibromyalgia secondary to the injection. The vaccinee needed to wrap her arm in an ice wrap at night and take analgesia as it was so painful. An x-ray of the left humerus on 24Feb03 was normal. At the time of the report the vaccinee was receiving physical therapy with positive slow progress and was still having some bad nights.
Sex: U
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site nodule, Skin burning sensation
Clinical narrative: A report was received from a health care professional on 25Oct02 concerning 7 vaccinees who experienced red, burning, hard nodules at the site of the injection, after receiving Fluvirin on 22Oct02. On 22Oct02, seven out of 68 employees who received Fluvirin at a community hospital experienced red, burning, hard nodules at the site of injection within a few hours. The vaccinees were seen in the ER. The vaccine was administered using a TB syringe with a prefixed needle. It was unk if the pt's recovered. The reporter suspects that these adverse effects are probably associated with this particular batch of Fluvirin. The following day, additional employees received Fluvirin from a different batch and no adverse effects were noted.  Update 1 20Feb03: A report was received from a health care professional concerning a vaccinee of unk demography who experienced raised red induration at the injection site 15 min after receiving Fluvirin on an unk date. The vaccinee had recovered at the time of the report. Three other vaccinees had the same reaction to the same batch. There was insufficient information to determine the reporters causality assessment. See Ref: PJP200200541, PJP200300089, PJP200300090.
Sex: U
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site nodule, Skin burning sensation
Clinical narrative: A report was received from a health professional on 25Oct02, concerning seven vaccinees who experienced red, burning, hard nodules at the site of injection, after receiving Fluvirin on 22Oct02. On 22Oct02, seven out of 68 employees who received Fluvirin at a community hospital experienced red, burning, hard nodules at the site of injection within a few hours. The vaccinees were seen in the ER. The vaccine was administered using a TB syringe with a prefixed needle. It was unk if the vaccinees recovered. The reporter suspects that these adverse effects are probably associated with this particular batch of Fluvirin. The following day, additional employees received Fluvirin from a different batch and no adverse effects were noted. Update 1 20Feb03: A report was received from health care professional concerning a vaccinee of unk demography who experienced raised red, induration at the injection site 15 min after receiving Fluvirin on an unk date. The vaccinee had recovered at the time of the report. Three other vaccinees had the same reaction to the same batch. There was insufficient information to determine the reporters causality assessment. See Ref: PJP200200541, PJP20030088, PJP200300090.
Sex: U
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site induration, Injection site mass, Injection site swelling
Clinical narrative: A report was received from a health professional on 10/25/2002, concerning seven vaccinees who experienced red, burning, hard nodules at the site of injection after receiving Fluvirin on 10/22/2002. On 10/22/2002, 7 out of 68 employees who received Fluvirin at a Community Hospital experienced red, burnign, hard nodules at the site of injection within a few hours. The vaccinees were seen in the emergency room. The vaccinee was administered using a TS syringe with a prefixed needle. It was unknown if the vaccinees reocvered. The reporter suspects that these adverse effects are probably associated with this particular batch of Fluvirin. The following day, additonal employees received Fluvirin from a different batch and no adverse effects were noted. Update1. 02/20/2003: A report was received from a health care professional concerning a vaccinee of unknown demography who experienced raised, red induration at the injection site 15 minutes after receiving Fluvirn on an unknown date. The vaccinee had recovered at the report. Three other vaccinees had the same reaction  to the same batch. There was insufficient information to determine the reporters causality assessment.  See Reference: PJP2002000541, PJP200300088, PJP200300090.
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was recieved from a consumer on 02/26/2003, concerning a male vaccinee of unknown demography who received Fluvirin intramuscularly on 02/26/2003. On 02/26/2003, the vaccinee was supposed to receive another vaccine via the intradermal route but was inadvertently given Fluvirin instead. No adverse event had occurred at the time of the report.
Sex: F
Vaccine: UNK
Symptoms: Keratitis, Periorbital oedema, Rheumatoid arthritis, Uveitis, Visual acuity reduced
Clinical narrative: A literature report was received on 03/24/2003, concerning a 77 year old female vaccinee who experienced recurrent uveitis, irritation, reduced visual acuity,  fever and malaise approximately 3 weeks after receiving virus influenza vaccine (brand unspecified) on approximately 10/30/1988. The vaccinee was part of a retrospective study to investigate the possibility that influenza vaccination is a cause of recurrent uveitis in patients with a history of pre-existing ocular inflammatory disease. The  vaccinee has a relevant history of rheumatoid arthritis and previous iritis induced by complicated eye surgery. On 11/19/1988 the vaccinee noted a sudden change in her left eye. She was examined by a physician who noted a mild periorbital flush and early "keratitis" A lubricating ointment was prescribed 48 hours later her visual acuity fell to 6/21 (20/70). Slit lamp examination revealed corneal striae, but no anterior chamber reaction. There were 1+ vitreous cell, vitreous haze, and biomicroscopic evidence of cystoid macular oedema. She was treated with  topical prednisone acetate 1% every 2 hours and ibuprofen (400mg).  Nine days later, her visual acuity improved to 6/6 (20/20) and the eye was quiet. Attempts to taper her medication produced a mild exacerbation, but her condition stabilized over the next 60 days. She was able to discontinue the medications with visual acuity of 6/6(20/20). The author concluded that influenza may act as a non specific stimulus of the immune system and thereby, reactive uveitis. The exposure to influenza vaccine triggered a recurrence of ocular inflammation. Update1. 05/06/2003: A report was received from a health care professional indicating that the vaccinee had recovered without sequalae on an unspecified date. Cross reference with: PJP200300142, PJP200300143, PJP200300146.
Sex: F
Vaccine: UNK
Symptoms: Vitreous disorder
Clinical narrative: A literature report was received on 03/24/2003, concerning a 77 year old female vaccinee who experienced recurrent uveitis, irritation, reduced visual acuity,  fever and malaise approximately 3 weeks after receiving virus influenza vaccine (brand unspecified) on approximately 10/30/1988. The vaccinee was part of a retrospective study to investigate the possibility that influenza vaccination is a cause of recurrent uveitis in patients with a history of pre-existing ocular inflammatory disease. The  vaccinee has a relevant history of rheumatoid arthritis and previous iritis induced by complicated eye surgery. On 11/19/1988 the vaccinee noted a sudden change in her left eye. She was examined by a physician who noted a mild periorbital flush and early "keratitis" A lubricating ointment was prescribed 48 hours later her visual acuity fell to 6/21 (20/70). Slit lamp examination revealed corneal striae, but no anterior chamber reaction. There were 1+ vitreous cell, vitreous haze, and biomicroscopic evidence of cystoid macular oedema. She was treated with  topical prednisone acetate 1% every 2 hours and ibuprofen (400mg).  Nine days later, her visual acuity improved to 6/6 (20/20) and the eye was quiet. Attempts to taper her medication produced a mild exacerbation, but her condition stabilized over the next 60 days. She was able to discontinue the medications with visual acuity of 6/6(20/20). The author concluded that influenza may act as a non specific stimulus of the immune system and thereby, reactive uveitis. The exposure to influenza vaccine triggered a recurrence of ocular inflammation. Update1. 05/06/2003: A report was received from a health care professional indicating that the vaccinee had recovered without sequalae on an unspecified date. Cross reference with: PJP200300142, PJP200300143, PJP200300146.
Age: 69.0
Sex: F
Vaccine: UNK
Symptoms: Erythema, Pain, Uveitis, Vision blurred
Clinical narrative: A literature report was received on 03/24/2003 concerning a 69 year old female vaccinee who experienced redness, discomfort, and blurred vision i the left eye approximately two weeks after  receiving influenza vaccine (brand unspecified) on approximately 10/01/1994. The vaccinee was part of a retrospective study to investigate the possibility that influenza vaccination  is a cause of recurrent uveitis in patients with a history of pre-existing ocular inflammatory disease. The vaccinee has a history of left  cataract removal by phacoemulisification in 1993, with post operative complications of iritis and vitritis which resolved by July 1994. The vaccinee never experienced and side effects with vaccinations. On 10/15/1994 the vaccinee presented complaining of redness, discomfort, and decreased vision in the left eye. Examination revealed a visual acuity of 6/12(20/40), 1+ cellular anterior chamber reaction, pseudophatic precipitates but no keratic precipitates and an intraocular pressure of 20 mm Hg. Fundus biomicroscopy revealed recurrent macular edema. The vaccinee was treated with prednisone acetate 1% daily every 1-2 hours for several days with a gradual decrease in dosage. The vaccinee reported that she treated herself for approximately 1 week, discontinued and then resumed the drops for several more days. Six weeks later she returned for examination, her eye had returned to normal Her visual acuity was 6/6(20/20) OS, slit lamp exam showed no uveitis, and intraocular pressure was 20 mm Hg. She had experienced no further disturbance since that time. The author concluded that influenza vaccination may act as a non specific stimulius of the immune system and theryby, reactivate uveitis. The exposure to influenza vaccine triggered recurrence of occular inflammation. Update1. 05/06/2003: A follow up report was received from a health care professional indicating that the vaccinee had recovered without sequalae, Cross Reference with: PJP200300141, PJP200300146, PJP200300143.
Age: 62.0
Sex: F
Vaccine: UNK
Symptoms: Eye disorder, Injection site mass, Iritis, Keratitis, Periorbital oedema
Clinical narrative: A literature report was received on 03/24/2003 concerning a 62 year old female vaccinee who experienced recurrent uveitis 6 days after vaccination with virus influenza vaccine (brand unspecified) ON 10/12/1994. The vaccine was part of a retrospective study to investigate the possibility that influenza vaccination is a cause of recurrent uveitis in patients with a history of pre-existing ocular inflammatory disease. The vaccinee has a previous history of right eye uveitis in May 1994. On 10/18/1994, the vaccinee presented with recurrent uveitis in the right eye. Her best-corrected visual acuity was 6/12(20/40) in the right eye. There was a trace ciliary flush, few, fine keartic precipitates, and a 1+ cell and flare in the anterior chamber. Scattered inflammatory nodules were noted at the iris border. Laboratory tests of complete blood  count with/ differential. SMA 12, sedimentation rate, fluorescent Treponema absorption test (FTA-ABS) , Rheumatoid factor, and angiotension converting enzyme, which were all within normal limits. The vaccinee was treated with topical diclofenac 0.1% TID, atropine sulfate 1% every day, and prednisone acetate 1% QID. The vaccinee recovered in 2 weeks. The authors concluded that influenza vaccination may act as a non-specific stimulus of the immune system and thereby, reactive uveitis, The exposure to influenza vaccine triggered a recurrence of the ocular inflammation. Update1. 05/06/2003: A report was received from a health care professional indicating that the vaccinee had recovered without sequelae on an unspecified date. Cross Reference with: PJP200300141, PJP200300142, PJP200300146.
Age: 62.0
Sex: F
Vaccine: UNK
Symptoms: Skin nodule, Uveitis, Visual acuity reduced
Clinical narrative: A literature report was received on 03/24/2003 concerning a 62 year old female vaccinee who experienced recurrent uveitis 6 days after vaccination with virus influenza vaccine (brand unspecified) ON 10/12/1994. The vaccine was part of a retrospective study to investigate the possibility that influenza vaccination is a cause of recurrent uveitis in patients with a history of pre-existing ocular inflammatory disease. The vaccinee has a previous history of right eye uveitis in May 1994. On 10/18/1994, the vaccinee presented with recurrent uveitis in the right eye. Her best-corrected visual acuity was 6/12(20/40) in the right eye. There was a trace ciliary flush, few, fine keartic precipitates, and a 1+ cell and flare in the anterior chamber. Scattered inflammatory nodules were noted at the iris border. Laboratory tests of complete blood  count with/ differential. SMA 12, sedimentation rate, fluorescent Treponema absorption test (FTA-ABS) , Rheumatoid factor, and angiotension converting enzyme, which were all within normal limits. The vaccinee was treated with topical diclofenac 0.1% TID, atropine sulfate 1% every day, and prednisone acetate 1% QID. The vaccinee recovered in 2 weeks. The authors concluded that influenza vaccination may act as a non-specific stimulus of the immune system and thereby, reactive uveitis, The exposure to influenza vaccine triggered a recurrence of the ocular inflammation. Update1. 05/06/2003: A report was received from a health care professional indicating that the vaccinee had recovered without sequelae on an unspecified date. Cross Reference with: PJP200300141, PJP200300142, PJP200300146.
Age: 51.0
Sex: F
Vaccine: FLUX
Symptoms: Ciliary muscle spasm, Flushing, Iritis, Ocular hyperaemia, Pain
Clinical narrative: A literature report was received on 24Mar03 concerning a 51 year old female vaccinee who experienced blurred vision, pain and redness associated with a recurrence of iritis in her left eye approx two weeks after vaccination with virus influenza in later Nov94. She had a history of scleritis and recurrent iritis in both eyes for 25 years. No underlying etiology was established for the inflammation and the last recurrence had been documented in 1990. The vaccinee was part of a retrospective study to investigate the possibility that influenza vaccination is a cause of recurrent uveitis in pt's with a history of pre-existing ocular inflammatory disease. In Dec 1994, the vaccinee presented with blurred vision, pain and redness associated with a recurrence of iritis in the left eye. Visual acuity was reduced to 6/7.5 (20/25). There was a mild ciliary flush in the left eye, fine keratic precipitates were scattered on the corneal endothelium and the anterior chamber showed 2+cells and a trace flare. There was no sign of recurrent scleritis.  Intraocular pressure was 15mm Hg by applanation. Fundus examination was unremarkable. The vaccinee was treated with topical dexamethasone 0.1% drops four times daily, topical atropine sulfate 1% twice daily, and systemic corticosteroids for seven days. The vaccinee fully recovered after 14 days. The authors concluded that influenza vaccination may act as a nonspecific stimulus of the immune system and thereby, reactivate uveitis. The exposure to influenza vaccine triggered a recurrence of ocular inflammation. Update 1, 06May03: A follow up report was received from a health care professional indicating that the vaccinee had recovered without sequelae. Cross ref with: PJP200300141, PJP200300142, PJP200300143.
Age: 51.0
Sex: F
Vaccine: FLUX
Symptoms: Vision blurred
Clinical narrative: A literature report was received on 24Mar03 concerning a 51 year old female vaccinee who experienced blurred vision, pain and redness associated with a recurrence of iritis in her left eye approx two weeks after vaccination with virus influenza in later Nov94. She had a history of scleritis and recurrent iritis in both eyes for 25 years. No underlying etiology was established for the inflammation and the last recurrence had been documented in 1990. The vaccinee was part of a retrospective study to investigate the possibility that influenza vaccination is a cause of recurrent uveitis in pt's with a history of pre-existing ocular inflammatory disease. In Dec 1994, the vaccinee presented with blurred vision, pain and redness associated with a recurrence of iritis in the left eye. Visual acuity was reduced to 6/7.5 (20/25). There was a mild ciliary flush in the left eye, fine keratic precipitates were scattered on the corneal endothelium and the anterior chamber showed 2+cells and a trace flare. There was no sign of recurrent scleritis.  Intraocular pressure was 15mm Hg by applanation. Fundus examination was unremarkable. The vaccinee was treated with topical dexamethasone 0.1% drops four times daily, topical atropine sulfate 1% twice daily, and systemic corticosteroids for seven days. The vaccinee fully recovered after 14 days. The authors concluded that influenza vaccination may act as a nonspecific stimulus of the immune system and thereby, reactivate uveitis. The exposure to influenza vaccine triggered a recurrence of ocular inflammation. Update 1, 06May03: A follow up report was received from a health care professional indicating that the vaccinee had recovered without sequelae. Cross ref with: PJP200300141, PJP200300142, PJP200300143.
Age: 77.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site reaction, Laboratory test abnormal
Clinical narrative: After having received a Pneumovax injection in her right upper deltoid, she developed a severe local reaction to the Pneumovax vaccine. Within hours after receiving the Pneumovax, the patient developed an exuberant, erythematous reaction of right upper arm with marked localized tenderness and induration.
Age: 0.51
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Convulsion, Hepatic enzyme abnormal, Hypotonia, Respiratory disorder, Speech disorder
Clinical narrative: Complex partial seizure 3- 5 minutes in length. Deviated eyes, blank stare, limpness, weird breathing pattern, postictal sleep for one hour. *Captured on video. 60 Day follow up: seizure disorder; speech delay (is not talking); elevated liver enzymes. Per follow up report-onging seizure disorder, elevated liver enzymes, developmental delays speech and sensory. Mother is now convinced the immunizations caused sons problems. He was vaccinated 22 shots in 6 months. Her son and daughter who are older and healthy had 1/2 the amount of shots their first six months of live. In the 2.5 years that my daughter was born and then younger son immunization schedule was changed. Many more immunizations were being given to infants in their early months of life. I don't understand the rush. Why not spread the immunizations out over the first 5 years of life? Why not go to single immunizations? Pediarix is terrible how it combines many vaccines at once. There is no need for this. I'm sure parents would rather have healthy children and more pricks than less pricks and unhealthy children. Also, why not test the titers of children before administering Booster shots. The titers of my children are sky high. They do not need Booster shots for the diseases they have already been vaccinated for. Our life and the life of our son is now forever changed because of an aggressive immunization schedule. Additionally, the medical bills we have incurred over the last 2 years are extremely high. They have no help in paying these bills. Mother knows they are not alone in sharing these opionons. She thinks the epidemic of Austistic children in this country needs immediate attention especialy with the big incidence occurring in boys.
Age: 0.51
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Staring, Vaccine positive rechallenge
Clinical narrative: Complex partial seizure 3- 5 minutes in length. Deviated eyes, blank stare, limpness, weird breathing pattern, postictal sleep for one hour. *Captured on video. 60 Day follow up: seizure disorder; speech delay (is not talking); elevated liver enzymes. Per follow up report-onging seizure disorder, elevated liver enzymes, developmental delays speech and sensory. Mother is now convinced the immunizations caused sons problems. He was vaccinated 22 shots in 6 months. Her son and daughter who are older and healthy had 1/2 the amount of shots their first six months of live. In the 2.5 years that my daughter was born and then younger son immunization schedule was changed. Many more immunizations were being given to infants in their early months of life. I don't understand the rush. Why not spread the immunizations out over the first 5 years of life? Why not go to single immunizations? Pediarix is terrible how it combines many vaccines at once. There is no need for this. I'm sure parents would rather have healthy children and more pricks than less pricks and unhealthy children. Also, why not test the titers of children before administering Booster shots. The titers of my children are sky high. They do not need Booster shots for the diseases they have already been vaccinated for. Our life and the life of our son is now forever changed because of an aggressive immunization schedule. Additionally, the medical bills we have incurred over the last 2 years are extremely high. They have no help in paying these bills. Mother knows they are not alone in sharing these opionons. She thinks the epidemic of Austistic children in this country needs immediate attention especialy with the big incidence occurring in boys.
Age: 1.97
Sex: M
Vaccine: DTAP, FLU3, HIBV, PNC
Symptoms: Urticaria
Clinical narrative: Hives lower right arm.  Benadryl 4 times a day.
Age: 14.0
Sex: F
Vaccine: FLU3, HEP
Symptoms: Nausea, Swelling face
Clinical narrative: Received immunization at 1PM 02/15/2005.  Went directly to dentist for treatment of "tooth infection".  Took ibuprofen on 02/15/2005. Nausea began around 9AM on 02/16/2005 at school, left school.  Swelling of lip began approximately 45 minutes later.  Has appointment with clinic at 1PM 02/16/2005 for treatment  Also had taken 500mg AMP on 02/16/2005.
Age: 3.0
Sex: M
Vaccine: FLU3, HEPA, PNC
Symptoms: Rash
Clinical narrative: Rash on trunk.
Age: 4.0
Sex: F
Vaccine: DTAP, FLU3, IPV, MMR
Symptoms: Erythema, Feeling hot
Clinical narrative: Right arm deltoid, 9x8cm red/warm area.
Age: 64.0
Sex: M
Vaccine: VARCEL
Symptoms: Decreased appetite, Dizziness, Fatigue, Headache, Joint stiffness
Clinical narrative: Evening of following day slightly feverish, next day slightly feverish, slightly nausea, slept all day.  Dizzy upon arising, fatigue.  Third day, fatigue easily, dizzy upon arising, appetite returned, nausea disappeared.  Body aches and strangely - hair hurt, actually scalp sensitive and running hand through hair was painful.  Neck ache and stiff shoulders, this lasted almost a week and a half.  No symptoms remain.
Age: 64.0
Sex: M
Vaccine: VARCEL
Symptoms: Nausea, Neck pain, Pain, Pyrexia
Clinical narrative: Evening of following day slightly feverish, next day slightly feverish, slightly nausea, slept all day.  Dizzy upon arising, fatigue.  Third day, fatigue easily, dizzy upon arising, appetite returned, nausea disappeared.  Body aches and strangely - hair hurt, actually scalp sensitive and running hand through hair was painful.  Neck ache and stiff shoulders, this lasted almost a week and a half.  No symptoms remain.
Age: 1.21
Sex: M
Vaccine: DTAPHEPBIP, MMR, PNC, VARCEL
Symptoms: Rash
Clinical narrative: Woke up in AM of 02/16/2005 with rash (red, raised, non-vesicular) to trunk which then spread to arms, legs, face.  Seen by physician on 02/17/2005 - unsure whether chicken pox or reaction to vaccines.  Spoke to patient's Mom on 02/18/2005 rash was improving and no other symptoms.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, PNC
Symptoms: Erythema, Sinusitis, Swelling
Clinical narrative: Swelling, Erythema left uppper arm.
Age: 0.33
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Crying, Injection site reaction, Irritability, Otitis media, Pyrexia
Clinical narrative: Severe and prolonged (18-24) crying, irritability and fever (102), mild local reaction, but tender. Pt. also with very mild uri and mild/minimal right otitis media.
Age: 0.33
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Tenderness
Clinical narrative: Severe and prolonged (18-24) crying, irritability and fever (102), mild local reaction, but tender. Pt. also with very mild uri and mild/minimal right otitis media.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Erythema, Swelling
Clinical narrative: Approx 3" X 2" red and swollen L upper arm. Warm moist soaks, Advil or motrin every 6 hours X 2 days
Age: 32.0
Sex: F
Vaccine: TTOX
Symptoms: Pyrexia
Clinical narrative: Patient states she started feeling like she had a fever around 4 pm. She took her temperature, which was 99.9 degrees F. She had no other symptoms or signs. She took some acetaminophen. She states she felt better shortly after and had no further feelings of fever.
Age: 1.08
Sex: F
Vaccine: OPV, VARCEL
Symptoms: Blister, Dysuria, Rash papular, Rash vesicular
Clinical narrative: Varicella rash , hundreds of vessicles/papules. Tx: Acyclovir 200 mg QID , Benadryl , Tylenol  Vessicles in vaginal area , painful to urinate
Age: 1.25
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Feeling hot, Injection site swelling, Urticaria
Clinical narrative: 8 days after varivax 4 little welts at site of injection and swelling and warmth a day later.
Age: 1.03
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Listless, Pyrexia, Rash maculo-papular
Clinical narrative: On 02/07/05, patient received varicella vaccine at 1:00 p.m. On 02/06/05, began a low grade fever, one papular lesion on face at 6:00 a.m. Babysitter called mother at noon, temperature increased to 103 degrees and child was seen at 1:00 p.m. by pediatrician. At that point child had several lesions, macular-papular rash at different stages on face, stomach, neck, back, buttocks and listlessness. Treated with pedialite and motrin for fever. No Known exposure to chicken pox. Improving on 02/17/05.
Age: 2.0
Sex: F
Vaccine: DTAP
Symptoms: Cellulitis, Feeling hot, Swelling
Clinical narrative: Received immunization 02/14/05, swelling started 02/15/05 in the a.m. Cellulitis today in office (02/16/05), 8" by 6". Will treat with antibiotic. Area hard, red, swollen, warm to touch.
Age: 40.0
Sex: F
Vaccine: TD
Symptoms: Erythema, Lethargy, Pain, Pyrexia, Swelling
Clinical narrative: Patient has fever of 101 degrees, red swollen arm, body aches and lethargy.
Age: 1.58
Sex: M
Vaccine: DTAP, HIBV, PNC
Symptoms: Decreased activity, Decreased appetite, Lethargy, Pyrexia, Vomiting
Clinical narrative: High temperature for 4 days of 104.5, 02/10/05 through 02/13/05. Also vomited twice, loss of appetite did not eat for 3 days, decreased activity and sometimes lethargic.
Age: 32.0
Sex: M
Vaccine: RAB
Symptoms: Arthralgia, Laboratory test abnormal, Rash
Clinical narrative: Rabies titer of 01/14/05 was .48. Received primary series of rabies (connaught) on 03/12/99, 03/18/99 and 04/1/99. Booster shot of Imovax was given 01/31/05. On 02/14/05, patient exhibits entire body rash. On 02/15/05, patient complained of arthralgia. Started on Benadryl on 02/14/05. 02/15/05, Benadryl discontinued and stared on Atarax.
Age: 3.0
Sex: M
Vaccine: HEPA
Symptoms: Diarrhoea, Lethargy, Malaise, Vomiting
Clinical narrative: Child felt sick, lethargic and vomited five times. No fever or diarrhea. Child was seen in office and felt better at 11:30 a.m. Later had diarrhea stool too. Child had restaurant food after shot.
Age: 2.0
Sex: M
Vaccine: PNC
Symptoms: Injection site reaction, Urticaria
Clinical narrative: Mother describes whelp at injection site and whelp on face.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Swelling, Tenderness
Clinical narrative: Right arm swelling and tenderness. Patient given Benadryl and Tylenol.
Age: 0.17
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Depressed level of consciousness, Somnolence
Clinical narrative: Increased sleep time noted since shots given, hard to arouse. Alert once awake but only awake approximately 5 to 10 minutes at a time.
Age: 1.22
Sex: U
Vaccine: MMR, UNK, VARCEL
Symptoms: Pruritus, Rash vesicular
Clinical narrative: Rash started 02/15/05, vesicular, widespread and pruritic.
Age: 0.45
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Rash
Clinical narrative: Immunizations given 02/10/2005.  Rash broke out 02/12/2005 - Benadryl, Grandmother saw nurse practitioner on 02/17/2005 who stated it was reaction to shots.
Age: 17.0
Sex: F
Vaccine: HEPA
Symptoms: Urticaria
Clinical narrative: Hives 56 hours after administered on torso.  Disappeared 4 hours after Benadryl.  Hives again 80 hours after administration - again resolved with Benadryl.
Age: 0.53
Sex: M
Vaccine: DTAPHEPBIP, PNC
Symptoms: Screaming, Somnolence
Clinical narrative: Patient Had excessive sleeping (5-7 hours) and screaming for 2-4 hours.
Age: 80.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Feeling hot, Pain, Pruritus, Swelling
Clinical narrative: Left arm swollen from shoulder to wrist - red, hot, painful, lasted for 5 days with itching.  Patient has never had a reaction to any vaccine before.
Age: 76.0
Sex: F
Vaccine: PPV
Symptoms: Back pain, Bradycardia, Dizziness, Syncope
Clinical narrative: Received pneumovax injection, waited in waiting area for lab.  As patient was getting blood drawn became dizzy and faint, put head down.  Unable to obtain pulse or blood presure, called 911.  Slowly began to respond drank juice, blood pressure 110/60, pulse 60, alert.  Transported to emergency room.  At time of blood draw, patient complained of severe pain in lower back which she attributed to pneumovax.  After waiting in ER she left before being seen by doctor.  EKG showed some brachycardia.
Age: 70.0
Sex: M
Vaccine: PPV
Symptoms: Feeling hot, Influenza like illness, Pain, Pyrexia, Swelling
Clinical narrative: Complete pneumovax injection was given to patient.  Patient complained of generalized ache and flu- like feeling afterwards.  Arm that received injection was sore and warm to touch.  Injection arm was also swollen across anterior, lateral, and dorsal portions and extended to about the middle of the lower arm.  There was no discoloration of the appendage.  Patient was afebrile before the injection and had a fever of 101.4 after injection.
Age: 39.0
Sex: F
Vaccine: HEP
Symptoms: Anxiety, Chest discomfort, Dizziness
Clinical narrative: Patient complained of dizziness, like someone sitting on her chest 20 minutes after receiving 2nd Hepatitis B immunization.  Taken to ER - Diagnosed with Anxiety still question allergic reaction.
Age: 0.34
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Pyrexia
Clinical narrative: No rash.  Vaccines yesterday.  Fever 104 this am.  Tylenol decreased fever to 103 after 3 degree protocol for fever followed (removed clothing and cool bath).  Temperature 100 in office 9:30AM 4 wet diapers - NL intake and urine output.  CBC within normal limits.  Flu A negative,  Flu B negative.  To follow up.
Age: 13.0
Sex: M
Vaccine: HEP
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Immediate swelling, redness around injection site - large.  Treatment - given diphenhydramine 50mg/ml intramuscular right deltoid.
Age: 1.51
Sex: F
Vaccine: DTAP
Symptoms: Convulsion, Pyrexia, Upper respiratory tract infection
Clinical narrative: Child had a DTaP (Daptacel, Sanofi-Pasteur) on 2/9/05.  Had mild URI symptoms.  Early the next morning, developed a fever and had a seizure.  Seen at hospital.  Felt to have had a febrile convulsion.  No apparent residual effects.
Age: 19.0
Sex: F
Vaccine: ANTH
Symptoms: Dermatitis atopic, Dry skin, Eczema, Hypersensitivity, Pruritus
Clinical narrative: Pt is a 23-year-old female who reports that 1-2 weeks following her second anthrax (AVA) on 21 Aug 2000 that she developed intense itching and dryness of her skin all over her body. She stated that she had a rash that consisted of tiny red bumps all over her body. She stated that they were not fluid filled. She then sought medical attention and was told that her skin was dry and to use Vaseline lotion and a humidifier. Then a couple of weeks later she noticed that the rash became fluid filled with a clear yellow fluid that started weeping, would dry and then the skin would crack. She said that her skin would bleed when it cracked, scab, and then fall off. She returned to the doctor and was told that she had atopic dermatitis and eczema and was given oral steroids for 2 weeks and used topical steroids for about 1 1/2 years. She stated that the cream and steroids would help but she did not like the side effects and that she would still have outbreaks so she sought a second opinion. She was referred to the dermatology and immunology clinic for skin testing and evaluation. She stated that she allergic to formaldehyde and mites. She stated that her medication was changed to Zyrtec, Elidel and a course of tetracycline. She reports that the medication helps to control her symptoms but that she still gets frequent outbreaks, especially while she is at work and exposure to any formaldehyde containing products, perfumes, smoke, and her uniforms. She states that her rash usually is not as bad at home but states that is because she has allergy proofed her house. She denies any other medical problems besides her skin.
Age: 19.0
Sex: F
Vaccine: ANTH
Symptoms: Rash
Clinical narrative: Pt is a 23-year-old female who reports that 1-2 weeks following her second anthrax (AVA) on 21 Aug 2000 that she developed intense itching and dryness of her skin all over her body. She stated that she had a rash that consisted of tiny red bumps all over her body. She stated that they were not fluid filled. She then sought medical attention and was told that her skin was dry and to use Vaseline lotion and a humidifier. Then a couple of weeks later she noticed that the rash became fluid filled with a clear yellow fluid that started weeping, would dry and then the skin would crack. She said that her skin would bleed when it cracked, scab, and then fall off. She returned to the doctor and was told that she had atopic dermatitis and eczema and was given oral steroids for 2 weeks and used topical steroids for about 1 1/2 years. She stated that the cream and steroids would help but she did not like the side effects and that she would still have outbreaks so she sought a second opinion. She was referred to the dermatology and immunology clinic for skin testing and evaluation. She stated that she allergic to formaldehyde and mites. She stated that her medication was changed to Zyrtec, Elidel and a course of tetracycline. She reports that the medication helps to control her symptoms but that she still gets frequent outbreaks, especially while she is at work and exposure to any formaldehyde containing products, perfumes, smoke, and her uniforms. She states that her rash usually is not as bad at home but states that is because she has allergy proofed her house. She denies any other medical problems besides her skin.
Age: 2.0
Sex: M
Vaccine: MMR
Symptoms: Dysphonia, Erythema, Pyrexia
Clinical narrative: 1. hoarse voice approximately 1-2 days following vaccine 2. fever (ranging from 100.6-102.3, rectal) began 10 days after vaccine was administered, lasting approximately 2 days. 3. red dots on hands and 1 leg (may not be related), occurred approximately same time as fever
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: The patient had a large red swollen area measuring 6 x 7.5 cm at the injection site.
Age: 5.0
Sex: M
Vaccine: DTAP, HEPA, IPV, MMR
Symptoms: Injection site erythema, Injection site swelling, Pruritus, Vomiting
Clinical narrative: Mother states child had redness& swelling in left arm at injection site on 2/21/05. On 2/22/05 mother states swelling increased, patient complained of itching in left arm and child vomited.
Age: 17.0
Sex: F
Vaccine: HEP, TD
Symptoms: Benign intracranial hypertension, Headache, Vision blurred
Clinical narrative: 2/22/05-Mother in the Health Unit to complete VAERS form due to the following sequence of events after receiving the Hepatitis B vaccine series.  Her mother states that she was previously diagnosed w/ high blood pressure, depression, and she is extremely overweight. Dates and information recorded as given by mother:  8-2-04  Patient received #1 Hep B Pedi/Adol at 1:30pm.  The injection site was left arm, given IM.  9-11-04  Patient complained of severe headache and pressure on the right side of her head.   9-13-04  Patient received #2 Hep B at 2:00pm.  The injection site was left arm given IM.  9-14-04  Patient complained of severe headache & pressure on right side of head. Seen at Clinic. NP ordered MRI of brain. Results of MRI abnormal. Ordered MRI of pituitary gland. Results-cyst on pituitary gland. Refer to neurologist. Ordered EEG-abnormal: diagnosed w/ Pseudotumor Cerebri. Spinal tap-pressure mildly elevated. 2nd opinion concurred w/ diagnosis of Pseudotumor Cerebri. In October 2004(?) Patient started having blurred vision along with severe headaches & pressure on right side of head.   11-19-04-seen by neuro ophthalmologist. He stated symptoms psychosomatic-ordered meds for headache, which decreased headache pain after 1 month. Vision remains 20/200 in both eyes; no corrective lens has been ordered since the eye doctor thinks these symptoms are temporary. Patient is home schooled.   12-13-04  3rd Hep B @ 10:30AM, left arm.   Patient is on following meds: Verapamil ER 180mgs daily, Lexapro 20mg BID, Diamox 500mg TID, Topamax 100mg HS, Furaset PRN-headache. She found information on line of other people w/ Pseudotumor Cerebri that believe their condition was caused by Hep B vaccine.
Age: 30.0
Sex: F
Vaccine: HEP
Symptoms: Eye pain, Fatigue, Headache, Injection site reaction, Neck pain
Clinical narrative: Reaction in injection site.  Headache pain in the right arm and shoulder and neck, fatigue, soreness, tingling, eye pressure pain.
Age: 30.0
Sex: F
Vaccine: HEP
Symptoms: Pain, Paraesthesia
Clinical narrative: Reaction in injection site.  Headache pain in the right arm and shoulder and neck, fatigue, soreness, tingling, eye pressure pain.
Age: 1.18
Sex: F
Vaccine: MMR
Symptoms: Erythema, Pyrexia, Rash, Urticaria, Vomiting
Clinical narrative: 02/15/05 Patient was given MMR #1 at 10:45 AM. 2 hours later vomited and red raised welt right thigh like rash. Hives with confluent notches , red face , severe on face and arms. Temperature 99.1 2/16. Given benadryl and sent to er.
Age: 2.0
Sex: F
Vaccine: SMALL
Symptoms: Cow pox, Skin ulcer
Clinical narrative: Marine father received smallpox vaccine 01/27/05. Patient - daug came in contact with vaccine site 02/06/05. She touched her forehead and broke out with one lesion mid forehead 02/12/05. Father received vaccine at Camp Pendleton Base.  Information from Follow-up report states: Daughter didn't receive vaccine. Inadvertent contact with Father's smallpox vaccine occured 2-12-05. Father had rec'd smallpox vaccine 1-27-05 for military service.
Age: 5.0
Sex: M
Vaccine: DTAPHEPBIP
Symptoms: Feeling hot, Injection site erythema, Injection site swelling, Tenderness
Clinical narrative: Swelling , redness , warmth at injection site. Area the size of a baseball slightly raised , itchy and then tender - lasted 4-5 days. Treated with prednisone x 7 days.
Age: 45.0
Sex: M
Vaccine: ANTH, ANTH
Symptoms: Albuminuria, Anaemia, Arthralgia, Asthma, Bone disorder
Clinical narrative: Multiple Myeloma, Asthma, Joint Pain, Erectile Dysfunction, Pneumonia, Optic Nerve Pain. Per follow up report received 05/06/2005:  Patient had not recovered. Medical records reviewed stated patient experienced thrombocytopenia, proteinuria, anemia and compression fractures of the spine.
Age: 45.0
Sex: M
Vaccine: ANTH, ANTH
Symptoms: Erectile dysfunction, Eye pain, Multiple myeloma, Neuralgia, Pneumonia
Clinical narrative: Multiple Myeloma, Asthma, Joint Pain, Erectile Dysfunction, Pneumonia, Optic Nerve Pain. Per follow up report received 05/06/2005:  Patient had not recovered. Medical records reviewed stated patient experienced thrombocytopenia, proteinuria, anemia and compression fractures of the spine.
Age: 45.0
Sex: M
Vaccine: ANTH, ANTH
Symptoms: Thrombocytopenia
Clinical narrative: Multiple Myeloma, Asthma, Joint Pain, Erectile Dysfunction, Pneumonia, Optic Nerve Pain. Per follow up report received 05/06/2005:  Patient had not recovered. Medical records reviewed stated patient experienced thrombocytopenia, proteinuria, anemia and compression fractures of the spine.
Age: 45.0
Sex: M
Vaccine: ANTH, ANTH
Symptoms: Abdominal pain, Arthralgia, Asthma, Bone pain, Dehydration
Clinical narrative: Multiple Myeloma, Asthma, Joint Pain, Erectile Dysfunction, Pneumonia, Optic Nerve Pain. Per follow up report received 05/06/2005:  Patient had not recovered. Medical records reviewed stated patient experienced thrombocytopenia, proteinuria, anemia and compression fractures of the spine.